Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What is 'LDL cholesterol'?

× No keyword cloud information.

17 in total

1. Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: Systematic review and meta-analysis of trials.

Authors: Safi U Khan; Muhammad U Khan; Shahul Valavoor; Muhammad Shahzeb Khan; Victor Okunrintemi; Mamas A Mamas; Thorsten M Leucker; Michael J Blaha; Erin D Michos
Journal: Eur J Prev Cardiol Date: 2019-09-02 Impact factor: 7.804

Review 2. Prevention of atherosclerosis from childhood.

Authors: Olli Raitakari; Katja Pahkala; Costan G Magnussen
Journal: Nat Rev Cardiol Date: 2022-01-05 Impact factor: 49.421

3. Apt interpretation of comprehensive lipoprotein data in large-scale epidemiology: disclosure of fundamental structural and metabolic relationships.

Authors: Mika Ala-Korpela; Siyu Zhao; Marjo-Riitta Järvelin; Ville-Petteri Mäkinen; Pauli Ohukainen
Journal: Int J Epidemiol Date: 2022-06-13 Impact factor: 9.685

Review 4. Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development.

Authors: Michael V Holmes; Tom G Richardson; Brian A Ference; Neil M Davies; George Davey Smith
Journal: Nat Rev Cardiol Date: 2021-03-11 Impact factor: 32.419

Review 5. Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.

Authors: Isabella Giacomini; Federico Gianfanti; Maria Andrea Desbats; Genny Orso; Massimiliano Berretta; Tommaso Prayer-Galetti; Eugenio Ragazzi; Veronica Cocetta
Journal: Front Oncol Date: 2021-05-24 Impact factor: 6.244

6. Atorvastatin Ester Regulates Lipid Metabolism in Hyperlipidemia Rats via the PPAR-signaling Pathway and HMGCR Expression in the Liver.

Authors: Nan Hu; Chunyun Chen; Jinhui Wang; Jian Huang; Dahong Yao; Chunli Li
Journal: Int J Mol Sci Date: 2021-10-14 Impact factor: 5.923

7. Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.

Authors: Tom G Richardson; Genevieve M Leyden; Qin Wang; Joshua A Bell; Benjamin Elsworth; George Davey Smith; Michael V Holmes
Journal: PLoS Biol Date: 2022-02-25 Impact factor: 8.029

8. Establishing reference intervals for triglyceride-containing lipoprotein subfraction metabolites measured using nuclear magnetic resonance spectroscopy in a UK population.

Authors: Roshni Joshi; Goya Wannamethee; Jorgen Engmann; Tom Gaunt; Deborah A Lawlor; Jackie Price; Olia Papacosta; Tina Shah; Therese Tillin; Peter Whincup; Nishi Chaturvedi; Mika Kivimaki; Diana Kuh; Meena Kumari; Alun D Hughes; Juan P Casas; Steve E Humphries; Aroon D Hingorani; A Floriaan Schmidt
Journal: Ann Clin Biochem Date: 2020-10-21 Impact factor: 2.057

9. Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke.

Authors: Shuai Yuan; Bowen Tang; Jie Zheng; Susanna C Larsson
Journal: Ann Neurol Date: 2020-10-10 Impact factor: 10.422

10. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.

Authors: Tom G Richardson; Eleanor Sanderson; Tom M Palmer; Mika Ala-Korpela; Brian A Ference; George Davey Smith; Michael V Holmes
Journal: PLoS Med Date: 2020-03-23 Impact factor: 11.069